Skip to main content
Skip to main content
NAII logo

Natural Alternatives International, Inc. (NAII) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$2.02 +$0.02 (+1.00%) |Weak · 36
Natural Alternatives International, Inc. (NAII) bottom line: signals are mixed — the Council read leans Split View (39/100) while the AI fundamental score is 36/100 (grade D); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $12.7M| Vol: 5K| 52-wk range: $1.98 – $4.96

Market cap $12.7M is the value of all shares combined. Beta 0.39: the stock has moved about 61% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Natural Alternatives International, Inc. (NAII) trades at $2.02 with MoonshotScore 36/100 (Grade D). Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements. They operate through private-label contract manufacturing and patent/trademark licensing. Market cap: $12.7M, Sector: Consumer defensive.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements. They operate through private-label contract manufacturing and patent/trademark licensing.

Analyst Coverage for NAII: NAII does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NAII against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the NAII film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 39/100 · D

NAII: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 36/100
Business Quality
Negative Is this a genuinely good business?
Financial Safety
Weak Could this blow up on me?
Valuation
Weak Am I paying a fair price?
Growth Durability
Neutral Is the growth real and likely to last?
Momentum
Weak Is the market already moving on this?

Strongest side: Growth Durability (5/10, Neutral). Weakest side: Business Quality (1/10, Negative).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Unfavorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Natural Alternatives International, Inc. (NAII) Consumer Business Overview

CEOMark A. LeDoux
Employees293
HeadquartersCarlsbad, CA, US
IPO Year1993

Natural Alternatives International, Inc. (NAII) operates within the consumer defensive sector, focusing on formulating, manufacturing, and marketing nutritional supplements. The company differentiates itself through private-label contract manufacturing and the licensing of its CarnoSyn and SR CarnoSyn brands, serving both direct-to-consumer and retail channels internationally.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for NAII?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Natural Alternatives International, Inc. presents a focused investment opportunity within the consumer defensive sector, specifically in the nutritional supplement market. The company's dual revenue streams—private-label contract manufacturing and patent licensing—provide diversification. However, a current profit margin of -9.1% warrants careful consideration. Growth catalysts include expanding its CarnoSyn brand and securing new private-label manufacturing contracts. Key value drivers are its established manufacturing capabilities and strategic partnerships. Investors should monitor the company's ability to improve profitability and manage competition within the nutritional supplement industry. The company's beta of 0.39 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

NAII Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $12.7M, indicating a small-cap company.

  • Gross margin of 8.6%, reflecting the profitability of its product sales after deducting direct costs.
  • Beta of 0.39, suggesting lower volatility compared to the overall market.
  • Operates in two segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing, diversifying its revenue streams.
  • Serves customers through direct sales, e-commerce channels, and retail stores, providing broad market access.

Who Are NAII's Competitors?

NAII is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
USNA USANA Health Sciences, Inc. $14.90 +0.47% $275M 615-pillar
NUTR NUSATRIP Inc $41.80 0.00% $628M
JVA Coffee Holding Co., Inc. $3.93 +14.58% $22.4M 775-pillar
WYHG Wing Yip Food Holdings Group Limited $4.52 -9.24% $56.9M 499-signal
LFVN LifeVantage Corporation $6.37 -2.15% $80.4M 615-pillar
FTLF FitLife Brands, Inc. $9.27 +0.54% $87.1M 605-pillar
SDSYA South Dakota Soybean Processors, LLC $7.10 0.00% $216M 459-signal
NATR Nature's Sunshine Products, Inc. $13.63 +0.16% $240M 455-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are NAII's Key Strengths?

Proprietary ingredients like CarnoSyn.

  • Established manufacturing capabilities.
  • Strategic partnering services.
  • International regulatory compliance expertise.

What Are NAII's Weaknesses?

Low profit margin (-9.1%).

  • Small market capitalization ($12.7M).
  • Limited brand recognition compared to larger competitors.
  • Dependence on a limited number of key customers.

What Could Drive NAII Stock Higher?

Potential new contracts for private-label manufacturing in the next 12-18 months.

  • Continued expansion of the CarnoSyn brand in the sports nutrition market.
  • Growth in the e-commerce channel for nutritional supplements.

What Are the Key Risks for NAII?

Financial-distress signal — its Altman Z-Score of 1.52 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-21.5%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Increased competition from larger contract manufacturers.
  • Regulatory changes impacting the nutritional supplement industry.
  • Fluctuations in raw material costs.
  • Dependence on key customer relationships.

What Are the Growth Opportunities for NAII?

  • Expansion of CarnoSyn Brand: NAII has the opportunity to further expand the market penetration of its CarnoSyn and SR CarnoSyn beta-alanine ingredients. The global beta-alanine market is projected to grow, driven by increasing demand from the sports nutrition and dietary supplement sectors. By investing in marketing and distribution, NAII can capitalize on this trend and increase its licensing revenue. Timeline: Ongoing.
  • Strategic Partnerships: Forming strategic partnerships with larger nutritional supplement companies and retailers can provide NAII with access to new markets and distribution channels. These partnerships can also lead to increased contract manufacturing orders and brand awareness. The strategic partnership market is constantly evolving, with companies seeking to expand their reach and product offerings. Timeline: Ongoing.
  • Product Innovation: Investing in research and development to create new and innovative nutritional supplement formulations can drive growth. By developing proprietary ingredients and products, NAII can differentiate itself from competitors and attract new customers. The nutritional supplement market is highly competitive, with companies constantly seeking to innovate and improve their product offerings. Timeline: Ongoing.
  • International Expansion: Expanding its operations into new international markets can provide NAII with significant growth opportunities. Emerging markets, in particular, offer strong growth potential due to increasing disposable incomes and growing health awareness. International expansion requires careful planning and execution, but the potential rewards are substantial. Timeline: Ongoing.
  • E-commerce Growth: Capitalizing on the growth of e-commerce by expanding its online presence and direct-to-consumer sales channels. The e-commerce market for nutritional supplements is growing rapidly, providing NAII with the opportunity to reach a wider audience and increase sales. Investing in digital marketing and online customer service is essential for success in this channel. Timeline: Ongoing.

What Threats Does NAII Face?

  • Intense competition in the nutritional supplement industry.
  • Changing consumer preferences and trends.
  • Regulatory changes and compliance requirements.
  • Economic downturns and reduced consumer spending.

What Are NAII's Competitive Advantages?

  • Proprietary Ingredients: Patented ingredients like CarnoSyn provide a competitive advantage.
  • Manufacturing Expertise: Established expertise in formulating and manufacturing nutritional supplements.
  • Strategic Partnerships: Long-term relationships with key customers and partners.
  • Regulatory Compliance: Expertise in navigating international regulatory and label law compliance.

What Does NAII Do?

Founded in 1980 and headquartered in Carlsbad, California, Natural Alternatives International, Inc. (NAII) has evolved into a key player in the nutritional supplement industry. The company operates through two primary segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. NAII provides comprehensive private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal supplements, and other health-related products. These services encompass customized product formulation, clinical studies, manufacturing, marketing support, international regulatory compliance, product registration, packaging design, and scientific research. NAII also licenses its patented beta-alanine ingredient under the CarnoSyn and SR CarnoSyn brands. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders, catering to a diverse range of customer needs. NAII's strategic partnering services extend to packaging and delivery system design, regulatory review, and customer-specific nutritional product formulation. The company serves a broad clientele, including companies that market nutritional supplements through direct sales, e-commerce, and retail channels, operating in the United States, Europe, Asia, and internationally.

What Products and Services Does NAII Offer?

  • Formulates nutritional supplements.
  • Manufactures nutritional supplements in various forms (capsules, tablets, powders).
  • Markets nutritional supplements internationally.
  • Provides private-label contract manufacturing services.
  • Licenses patents and trademarks for ingredients like CarnoSyn.
  • Offers strategic partnering services including product formulation and regulatory compliance.

How Does NAII Make Money?

  • Generates revenue through private-label contract manufacturing of nutritional supplements.
  • Earns licensing fees from its patented CarnoSyn and SR CarnoSyn ingredients.
  • Provides strategic partnering services to nutritional supplement companies.
  • Sells its products to companies that market through direct sales, e-commerce, and retail channels.

What Industry Does NAII Operate In?

Natural Alternatives International, Inc. operates in the competitive packaged foods industry, specifically within the nutritional supplement segment. The global nutritional supplement market is characterized by increasing consumer awareness of health and wellness, driving demand for vitamins, minerals, and herbal supplements. Key trends include personalized nutrition, clean label products, and e-commerce growth. NAII competes with other contract manufacturers and ingredient suppliers, differentiating itself through its CarnoSyn brand and comprehensive service offerings. The company's success depends on its ability to innovate, maintain quality standards, and adapt to changing consumer preferences.

Who Are NAII's Key Customers?

  • Companies that market nutritional supplements through direct sales channels.
  • Companies that market nutritional supplements through direct-to-consumer e-commerce channels.
  • Companies that market nutritional supplements through retail stores.
  • Other health care product companies.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

Medium 74/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scored on 91% of our measures
  • Price is current
  • Latest filing 115 days ago
  • No analyst coverage

Why 36?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.54 Price to book (Valuation)
  • +0.29 Enterprise value vs sales (Valuation)
  • +0.29 Free cash flow growth (Growth)

What is holding it back

  • -0.78 Free cash flow yield (Business Quality)
  • -0.54 Earnings yield (Valuation)
  • -0.54 Free cash flow yield (Valuation)

Risk penalties applied

  • -0.06 Bankruptcy-risk score in the grey zone
  • -0.86 Loss-making and burning cash

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 33
2026-08-26 33
2026-08-29 33
2026-09-01 37
2026-09-04 37
2026-09-07 36
2026-09-10 36

What changed?

The grade moved from 33 to 36 (+3).

What moved it up or down:

  • +14 Valuation
  • +6 Growth Durability
  • +2 Business Quality

Held back by:

  • -19 Financial Safety

Over the same 18 days the stock moved -6.0%.

Natural Alternatives International, Inc. (NAII) Valuation Context

Valued at $12.7M, NAII is classified as a micro-cap stock. Relative to its peer group, NAII's quantitative score of 36/100 is below the peer average of 57/100.

NAII Revenue & Earnings Trend

In Q3 FY2025, NAII generated $35.3M in top-line revenue, marking a sequential increase of 2.3%. The company recorded a net loss of $4.3M, with diluted EPS of $-0.72. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, NAII averaged $-0.59 in diluted EPS.

Company Profile

Natural Alternatives International, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Carlsbad, US. The company is led by CEO Mark A. LeDoux. NAII has traded publicly since 1993.

ROE -21%

Key Financial Metrics

Return on equity for Natural Alternatives International, Inc. stands at -21.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -58.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -97.7%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9

Financial Health

Natural Alternatives International, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.52 places it in the distress zone, a signal of elevated financial risk.

Net buying

Insider Activity

The most recent 12 insider filings for Natural Alternatives International, Inc. break down as 3 sales and 9 purchases. On net that is roughly 59K shares acquired (about $32K) — insiders putting money in tends to read as conviction.

NAII Financials

Fundamental Snapshot

Revenue Growth (FY)
+14.1%
Net Income Growth (FY)
-88.1%
EPS Growth (FY)
-85.4%
Free Cash Flow Growth (FY)
+151.4%
Return on Equity (TTM)
-21.5%
Current Ratio
1.6

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • Proprietary ingredients like CarnoSyn.
  • Established manufacturing capabilities.
  • Strategic partnering services.
  • International regulatory compliance expertise.

Bear Case

  • Low profit margin (-9.1%).
  • Small market capitalization ($12.7M).
  • Limited brand recognition compared to larger competitors.
  • Dependence on a limited number of key customers.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 FY2025 $35M -$4M -$0.72
Q2 FY2025 $35M -$3M -$0.42
Q1 FY2025 $37M -$291,000 -$0.05
Q4 FY2024 $34M -$7M -$1.17

Q3 FY2025 · filed 19 May 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

NAII Latest News

NAII Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NAII.

Price Targets

Wall Street price target analysis for NAII.

NAII MoonshotScore

36/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. NAII scores 36/100 (Grade D): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Mark A. LeDoux

CEO

Mark A. LeDoux has served as the Chief Executive Officer of Natural Alternatives International, Inc. since its inception. His extensive background in the nutritional supplement industry spans several decades. He has been instrumental in guiding the company's strategic direction and fostering its growth. LeDoux's expertise encompasses product development, manufacturing, marketing, and international regulatory compliance. He is a recognized leader in the industry and has been actively involved in shaping industry standards and regulations.

Track Record: Under Mark A. LeDoux's leadership, Natural Alternatives International, Inc. has established itself as a reputable provider of private-label contract manufacturing services and a leading supplier of beta-alanine ingredients. He has overseen the expansion of the company's manufacturing facilities and the development of its strategic partnering services. LeDoux has also been instrumental in securing key customer relationships and driving the growth of the CarnoSyn brand.

Natural Alternatives International, Inc. Consumer Defensive Stock: Key Questions Answered

What does the AI Score mean for NAII?

NAII holds an AI Score of 36/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements. They operate through private-label contract manufacturing and patent/trademark licensing.

Is NAII a good stock?

Stock Expert AI does not rate NAII buy, sell or hold. Natural Alternatives International, Inc. carries a MoonshotScore of 36/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about NAII stock?

As of 2026-05-10, analyst coverage of Natural Alternatives International, Inc. (NAII) is limited due to its small market capitalization. Key valuation metrics include its market cap of $12.7M and a negative profit margin of -9.1%.

What are the key factors to evaluate for NAII?

Natural Alternatives International, Inc. (NAII) holds a MoonshotScore of 36/100 (low). The company's beta of 0.39 suggests lower volatility compared to the broader market. Not financial advice.

How frequently does NAII data refresh on this page?

NAII's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven NAII's recent stock price performance?

Natural Alternatives International, Inc. (NAII) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary ingredients like CarnoSyn. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NAII overvalued or undervalued right now?

Natural Alternatives International, Inc. (NAII) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of NAII?

Yes, most major brokerages offer fractional shares of Natural Alternatives International, Inc. (NAII) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track NAII's earnings and financial reports?

Natural Alternatives International, Inc. (NAII) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for NAII earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available company data and industry reports.
  • Financial data is as of the latest available reporting period.
  • Analyst opinions are based on limited coverage.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover